Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

285 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

3009 (91%)

3305

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

411 (94%)

Reversed:

23 (5%)

436

485 (13%)

40 (14%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-03-12 2020-08-27 108601
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-11-06 2021-01-07 128028
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2024-12-10 2025-04-24 245304
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144454
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-07-03 2026-03-12 261785
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-04-23 2020-08-27 113031
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144494
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144448
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144451
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144497
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-01-30 2025-04-24 249198
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-02-21 2020-04-09 106925
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-08-14 2026-03-12 265143
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2024-12-20 2026-03-12 246267
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-08-06 2020-11-07 121865
VINORELBINE TARTRATE FOR INJECTION 10MG SOLUTION Resolved 2017-08-01 2018-05-08 17779

Showing 3281 to 3300 of 3305

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEFERASIROX 125MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103791
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-03-20 2025-03-20 253156
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-05-28 2025-05-28 258443
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-04-25 2025-04-25 255812
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-05-28 2025-05-28 258440
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2025-04-29 2025-04-29 256131
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2025-05-28 2025-05-28 258446
TEVA-DICLOFENAC-K 50MG TABLET Discontinued 2025-05-28 2025-05-28 258427
TEVA-DICLOFENAC-K 50MG TABLET Discontinued 2025-03-20 2025-03-20 253168
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85572
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
TEVA-DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85575
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DOMPERIDONE 10MG TABLET Discontinued 2025-09-02 2025-09-02 266356
TEVA-DONEPEZIL 5MG TABLET Discontinued 2025-05-28 2025-05-28 258634
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491